Скачать с ютуб RetiSpec Closes $10M for AI-Driven Early Alzheimer's Eye Test в хорошем качестве

RetiSpec Closes $10M for AI-Driven Early Alzheimer's Eye Test

RetiSpec – a member of StartUp Health's Alzheimer's Moonshot Community – is on a health moonshot mission to enable widespread early and accurate detection of neurodegenerative disease markers with accessible, affordable, and scalable AI-driven retinal imaging. In this interview shot at the recent Alzheimer's Association International Conference (AAIC), Catherine Bornbaum, PhD, Chief Business Officer of RetiSpec, talks about RetiSpec's development of a point-of-care and AI-driven early detection solution for Alzheimer’s, through a simple eye exam. 🧠 Innovative Alzheimer’s Detection: RetiSpec uses deep learning models with fundus cameras to detect early signs of Alzheimer's disease through eye examinations. 💰 Successful Fundraising: RetiSpec recently raised $10 million, led by iGan Partners, with strategic investors like Eli Lilly Ventures and Topcon Healthcare. 👁️ Technology Integration: RetiSpec’s device easily integrates with existing eye exam equipment, allowing optometrists to screen for brain health issues during routine eye exams. 🌍 Clinical Impact: Pilots sponsored by the Davos Alzheimer’s Collaborative showed promising integration in optometry clinics, improving access to brain health diagnostics. --- Connect with Health Transformers: https://www.startuphealth.com/community Become a Health Moonshot Champion: https://www.startuphealth.com/funders Apply to Health Transformer University: https://www.startuphealth.com/founders Connect with StartUpHealth: Website: https://www.startuphealth.com/ Instagram:   / startuphealth   Twitter:   / startuphealth   Podcast: https://startup-health-now.blubrry.net/